Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity
about
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific ImmunotherapyRecombinant allergens: the present and the futureEvidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neckImmunological mechanisms of allergen-specific immunotherapyIdentification of critical amino acids in an immunodominant IgE epitope of Pen c 13, a major allergen from Penicillium citrinumMolecular approach to allergy diagnosis and therapyGenetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccinationSynthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cellsRecombinant house dust mite allergens.Transmission of allergen-specific IgG and IgE from maternal blood into breast milk visualized with microarray technology.Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoReduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients.Modern approaches to therapeutic vaccination as treatment for type 1 respiratory hypersensitivity (allergy) treatment.Molecular approaches for new vaccines against allergy.Allergy testing: the role of recombinant allergens.Sublingual immunotherapy of allergic diseases.A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (Ambrosia artemisiifolia).Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy.Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.Immunological mechanisms of allergen-specific immunotherapy.Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives.Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.Immunological mechanisms for desensitization and tolerance in food allergy.New directions in immunotherapy.Recombinant allergen-based provocation testing.Allergen immunotherapy for birch pollen-allergic patients: recent advances.Investigational new drugs for allergic rhinitis.Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination.Allergen-specific immunotherapy of allergy and asthma: current and future trends.Utility and Comparative Efficacy of Recombinant Allergens Versus Allergen Extract.Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.Enhancement of the frequency and function of IL-10-secreting type I T regulatory cells after 1 year of cluster allergen-specific immunotherapy.Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.Next generation immunotherapy for tree pollen allergies.The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses.Suppression of dust mite allergy by mucosal delivery of a hypoallergenic derivative in a mouse model.Antigens drive memory IgE responses in human allergy via the nasal mucosa.
P2860
Q26852113-D65BF9D6-8E87-4EB5-9CE6-D1D17F7AC9FCQ26996701-BE11B8DE-4150-4118-B1BC-2FE3B278C3D6Q28070005-C65C5D05-6874-466F-8664-1D4E5BE4CA3FQ28265326-4ADA3B1F-8927-4589-8D69-E41207A52C80Q28482224-8F0D9750-E9B7-446B-8AA3-B22ADC5C8F03Q33822511-20126A20-47F1-4A5C-A891-58AB37B18082Q33883053-8758CD61-D9EC-4396-8BBE-CF44C37A132BQ34329409-B9882EF9-0925-4F60-82A0-FA8811449383Q34361546-EE7C597F-3F01-4F11-82D6-DB8D784A9755Q34451581-41EF6E04-4B95-4572-AA7E-DD4DE39815A9Q35777126-75D25AB0-8D40-4DB5-9B97-9BAEADE76375Q36024279-8FBEF022-E664-49C6-989A-C4B8D7D55164Q36125684-0A73B489-14C6-4694-A9BC-230C94DB2091Q36383791-AACA019F-573E-42E7-B545-C3C4E33332DBQ36383819-617026BC-77BF-417C-90C9-56D7C71720BEQ36395501-E50DBFB2-2EE1-4253-A083-C9A2F79308ADQ36583727-CB3BC48B-4E3C-4D4F-801F-E669C64C38E1Q37652965-766CED06-6665-4B73-A255-CF544CEE2C46Q37732900-5A4F62AE-920A-4A7E-8886-BE9AB2E286DEQ37847222-75E7B60D-FBE3-41DA-9985-052CD2AACB8BQ37861875-B4F4CC01-44F1-4855-BC2F-B6BAF9FDF0BEQ37958561-635D1652-B259-4191-8C9F-00AF0A004BF6Q38013789-087C41E2-CFBB-404E-BB95-C8DF0A4A4D13Q38028369-C08162C1-DA2C-401A-B79B-1C2E3CA0D651Q38073718-7A40D40E-C6BF-4855-AE0F-343A311B087CQ38127011-F61EA88F-92ED-4D19-946E-DC263B9825D4Q38824177-8CB76999-9EDE-4199-B0DE-B5FA1E878F20Q39111947-CD311DEE-F342-4329-82A4-55CE1133736AQ39115606-C4E25DE5-40A1-4BF5-A8CC-E413CDBA8BF2Q39343215-435A3158-6078-422D-AD62-0B49F09174C7Q40006542-152B8EEB-8304-4497-9AC5-77B24D30C2C3Q40087434-C9738A28-8522-41C4-A799-678BC3054F28Q41196294-CC27D969-F0BE-4ECE-B323-31B1E1F8C574Q41769755-70A9FBB2-40C0-42CB-BBCC-9426193953C0Q47323888-38C33646-EDFD-461E-8335-B651891CC5BCQ47653403-180EAD14-63B5-4DDF-ACA8-C86998E31D35Q47884083-5EBF3E4C-1DB3-4F1F-93C1-651FEB591EDCQ49891958-44FB9909-E4FE-40C6-9FFA-EA81A7E8F3B6Q51010282-0FFD5355-E158-44A4-9E63-C21580756761Q51978305-C271E2D0-F76B-4F8A-9EB6-33388ADC0E17
P2860
Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity
description
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2005
@uk
name
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@en
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@nl
type
label
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@en
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@nl
prefLabel
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@en
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@nl
P2093
P50
P1476
Allergen-specific nasal IgG an ...... ced nasal allergen sensitivity
@en
P2093
Friedrich Horak
Gabrielle Pauli
Jürgen Reisinger
Oliver Cromwell
Verena Niederberger
P304
P356
10.1016/J.JACI.2005.04.003
P407
P577
2005-08-01T00:00:00Z